Regeneron to supply 1.4M additional REGEN-COV doses to U.S. Government for $2.94B

REGENERON PHARMACEUTICALS, INC.

Amendment obligates U.S. Government to buy 1.4 million doses at $2,100 each, totaling $2.94 billion.
Regeneron must deliver at least 100,000 doses per month (Sept–Dec 2021); all by January 31, 2022.
Doses are for use under FDA Emergency Use Authorization for certain individuals in the U.S.
Agreement includes government's right to terminate for convenience; Regeneron gets termination costs based on work performed.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.